Innovations In Clinical Neuroscience

MAR-APR 2018

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 45 of 55

H O T T O P I C S I N N E U R O S C I E N C E 46 ICNS INNOVATIONS IN CLINICAL NEUROSCIENCE March-April 2018 • Volume 15 • Number 3–4 hippocampal cell death following closed-head traumatic brain injury in rats. Neuroreport. 2016;27(10):724. 6. McGinn MJ, Povlishock JT. Pathophysiology of traumatic brain injury. Neurosurg Clin N Am. 2016;27(4):397–729. 7. Jorge R, Robinson RG. Mood disorders following traumatic brain injury. Int Rev Psychiatry. 2003;15: 317–327. 8. Alderfer BS, Arciniegas DB, Silver JM. Treatment of depression following traumatic brain injury. J Head Trauma Rehabil. 2005;20(6):544–562. 9. Dikmen SS, Bombardier CH, Machamer JE, et al. Natural history of depression in traumatic brain injury. Arch Phys Med Rehabil. 2004;85(9):1457– 1464. 10. Ghroubi S, Feki I, Chelly H, et al. Neurophysiological and behavioral disorders and their correlations with the severity of the traumatic brain injury. Ann Phys Rehabil Med. 2016;59S:e134. 11. Bombardier CH, Fann JR, Temkin NR, et al. Rates of major depressive disorder and clinical outcomes following traumatic brain injury. JAMA. 2010;303(19):1938–1945. 12. Jorge RE, Robinson RG, Moser D. Major depression following traumatic brain injury. Arch Gen Psychiatry. 2004;61(1):42–50. 13. Spitz G, Always Y, Gould KR, Ponsford JL. Disrupted white matter microstructure and mood disorders after traumatic brain injury. J Neurotrauma. 2017;34(4): 807–815. 14. Annegers JF, Coan SP. The risks of epilepsy after traumatic brain injury. Seizure. 2000;9(7):453–457. 15. Jorge RE, Acion L, Burin DI, et al. Sertraline for preventing mood disorders following traumatic brain injury: a randomized clinical trial. JAMA Psychiatry. 2016;73(10):1041–1047. 16. Ashman TA, Cantor JB, Gordon WA, et al. A randomized, controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. Arch Phys Med Rehabil. 2009;90(5):733–740. 17. Baños JH, Novack TA, Brunner R, et al. Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury. J Head Trauma Rehabil. 2010;25(5):357–361. 18. Prudic J. Electroconvulsive therapy. In: BJ Sadock, VA Sadock, and P Ruiz, eds. Kaplan & Sadock's Comprehensive Textbook of Psychiatry Philadelphia, PA: Lippincott Williams & Wilkins; 2009:3285– 4520. 19. Leiknes KA, Jarosch-von Schweder L, Høie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav. 2012;2(3):283–344. 20. Liu Y, Du L, Li Y, et al. Antidepressant effects of electroconvulsive therapy correlate with subgenual anterior cingulate activity and connectivity in depression. Medicine (Baltimore). 2015;94(45):e2033. 21. Leaver AM, Espinoza R, Pirnia T, et al. Modulation of instrinsic brain activity by electroconvulsive therapy in major depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1(1):77–86. 22. Mulders PC, van Eijndhoven PF, Pluijmen J, et al. Default mode network coherence in treatment-resistant major depressive disorder during electroconvulsive therapy. J Affect Disord. 2016;205:130–137. 23. Van Eijndhoven P, Mulders P, Kwekkeboom L, et al. Bilateral ECT induces bilateral increases in regional cortical thickness. Transl Psychiatry. 2016;6(8):e874. 24. Inta D, Lima-Ojeda JM, Lau T, et al. Electroconvulsive therapy induces neurogenesis in frontal rat brain areas. PLoS One. 2013;8(7):e69869. 25. Madsen TM, Treschow A, Bengzon J, et al. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47(12):1043–1049. 26. Bocchio-Chiavetto L, Znardini R, Bortolomasi M, et al. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol. 2006;16(8):620–624. 27. Minelli A, Zanardini R, Abate M, et al. Vascular endothelial growth factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(5):1322–1325. 28. Benson-Martin JJ, Stein DJ, Baldwin DS, et al. Genetic mechanisms of electroconvulsive therapy response in depression. Hum Psychopharmacol. 2016;31(3): 247–251. 29. Jiang J, Wang J, Li C. Potential mechanisms underlying the therapeutic effects of electroconvulsive therapy. Neurosci Bull. 2017;33(3):339–347. 30. Lopim GM, Vannucci CD, Gomes da Silva S, et al. Relationship between seizures frequency and number of neuronal and non-neuronal cells in the hippocampus throughout the life of rats with epilepsy. Brain Res. 2016;1634:179–186. 31. Martino C, Krysko M, Petrides G, et al. Cognitive tolerability of electroconvulsive therapy in a patient with a history of traumatic brain injury. J ECT. 2008;24(1):92–95. 32. Ruedrich SL, Chu CC, Moore SL. ECT for major depression in a patient with acute brain trauma. Am J Psychiatry. 1983;140(7):928. 33. Crow S, Meller W, Christenson G, Mackenzie T. Use of ECT after brain injury. Convuls Ther. 1996;12(2):113–116. ICNS

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - MAR-APR 2018